Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $150.33
-
Support level$134.76
-
Resistance levelN/A
-
Beta0.1
-
RSI (14-day)65.1
- With a 78.9 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- MRK is one of this month's top performers with a return of 16.9 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $77.60 | $156.45 | 94.3% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $118.40 | $134.59 | $145.03 | $151.00 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.3%
-
In the next month13.9%
-
In the next year58.0%
| Period | Value |
|---|---|
| Historical (5 year) | 24.6% |
| Last month | 23.0% |
| Current estimate | 23.4% |
| Next month forecast | 24.5% |